A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2027

Conditions
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Interventions
BIOLOGICAL

Efgartigimod PH20 SC

Subcutaneous administration of efgartigimod

Trial Locations (147)

116

Investigator site 8860012, Taipei

Investigator site 8860016, Taipei

333

Investigator site 8860017, Taoyuan District

701

Investigator site 8860013, Tainan City

1038

Investigator site 31, Riga

1090

Investigator site 0430005, Vienna

1105

Investigator site 0310010, Amsterdam

1113

Investigator site 3590005, Sofia

1200

Investigator site 320022, Woluwe-Saint-Lambert

1431

Investigator site 3590008, Sofia

1680

Investigator site 3590006, Sofia

2100

Investigator site 0450001, Copenhagen

3000

Investigator site 0320009, Leuven

3015

Investigator site 0310011, Rotterdam

4000

Investigator site 320024, Liège

4021

Investigator site 0430008, Linz

4600

Investigator site 9950020, Kutaisi

5000

Investigator site 0450003, Odense

5800

Investigator site 3590007, Pleven

8200

Investigator site 0450002, Aarhus

10016

Investigator site 10168, New York

11000

Investigator site 3810001, Belgrade

Investigator site 3810003, Belgrade

16059

Investigator site 900025, Bursa

16132

Investigator site 0390024, Genova

19107

Investigator site 0010007, Philadelphia

19126

Investigator site 0010047, Philadelphia

20122

Investigator site 0390003, Milan

23298

Investigator site 0010061, Richmond

24105

Investigator site 0490016, Kiel

27517

Investigator site 0010003, Chapel Hill

28040

Investigator site 0340018, Madrid

32209

Investigator site 0010023, Jacksonville

32751

Investigator site 0010068, Maitland

33008

Investigator site 0860040, Nanchang

33076

Investigator site 0330013, Bordeaux

33136

Investigator site 0010059, Miami

33487

Investigator site 0010072, Boca Raton

33612

Investigator site 0010006, Tampa

37075

Investigator site 490021, Göttingen

40536

Investigator site 10147, Lexington

43024

Investigator site 3800008, Lutsk

43210

Investigator site 0010064, Columbus

44093

Investigator site 330022, Nantes

44791

Investigator site 490044, Bochum

45147

Investigator site 490045, Essen

49069

Investigator Site 3800012, Dnipro

50139

Investigator site 390029, Florence

52242

Investigator site 0010011, Iowa City

55239

Investigator site 900022, Samsun

56125

Investigator site 0390023, Pisa

63003

Investigator site 330033, Clermont-Ferrand

66205

Investigator site 0010015, Fairway

67098

Investigator site 0330020, Strasbourg

69068

Investigator site 3800011, Zaporizhzhya

76008

Investigator Site 3800010, Ivano-Frankivsk

78229

Investigator site 0010009, San Antonio

78756

Investigator Site 0010066, Austin

80112

Investigator site 0010057, Centennial

85018

Investigator site 0010013, Phoenix

85028

Investigator site 0010055, Scottsdale

87042

Investigator site 0330024, Limoges

92011

Investigator site 0010032, Carlsbad

94109

Investigator site 0010071, San Francisco

94275

Investigator site 0330023, Le Kremlin-Bicêtre

98125

Investigator site 390027, Messina

117186

Investigator site 0070020, Moscow

Investigator site 70021, Moscow

194354

Investigator site 0070014, Saint Petersburg

250012

Investigator site 0860031, Jinan

300723

Investigator site 040003, Timișoara

310003

Investigator site 0860035, Hangzhou

344022

Investigator site 0070019, Rostov-on-Don

420021

Investigator site 070017, Kazan'

420097

Investigator site 0070023, Kazan'

430032

Investigator site 0070021, Saransk

430040

Investigator site 0860034, Wuhan

430060

Investigator site 0860029, Wuhan

500299

Investigator site 040002, Brasov

510120

Investigator site 0860050, Guangzhou

710038

Investigator site 0860048, Xi'an

712000

Investigator site 0860054, Xianyang

900591

Investigator site 040004, Constanța

6423906

Investigator site 9720004, Tel Aviv

35233-2110

Investigator site 0010065, Birmingham

91767-2009

Investigator site 10190, Pomona

92270-4150

Investigator site 0010160, Rancho Mirage

33067-4640

Investigator site 0010144, Coral Springs

Unknown

Investigator site 0430007, Innsbruck

Investigator site 0320016, Edegem

Investigator site 0860033, Beijing

Investigator site 860041, Changsha

Investigator site 0860036, Chengdu

Investigator site 0860038, Fuzhou

Investigator site 0860032, Guanzhou

Investigator site 0860045, Guiyang

Investigator site 0860043, Nanjing

Investigator site 0860028, Shanghai

Investigator site 860047, Shanghai

Investigator site 0860042, Tianjin

Investigator site 00330034, Angers

Investigator site 0330035, Paris

Investigator site 9950002, Tbilisi

Investigator Site 9950003, Tbilisi

Investigator site 0490013, Cologne

Investigator site 0490019, Potsdam

Investigator site 0390022, Brescia

Investigator site 0390026, Milan

Investigator site 0390042, Torino

Investigator site 0810035, Bunkyō City

Investigator site 0810002, Chiba

Investigator site 0810065, Ginowan

Investigator site 0810066, Hakodate

Investigator site 0810058, Hiroshima

Investigator site 0810029, Kawagoe

Investigator site 0810064, Tokushima

Investigator site 0810060, Yokohama

Investigator site 3810004, Kragujevac

Investigator site 0340038, Barcelona

Investigator site 900021, Izmir

Investigator site 440026, London

Investigator site 0440016, Oxford

Investigator site 0440018, Sheffield

024000

Investigator site 860049, Chifeng

500-03

Investigator site 4200010, Hradec Králové

06202

Investigator site 0330021, Nice

0112

Investigator site 9950004, Tbilisi

Investigator site 9950005, Tbilisi

00189

Investigator site 0390008, Roma

183-0042

Investigator site 0810030, Fuchū

812-8582

Investigator site 0810031, Fukuoka

187-8551

Investigator site 0810026, Kodaira

616-8255

Investigator site 810061, Kyoto

321-0293

Investigator site 0810027, Mibu

466-8560

Investigator site 0810032, Nagoya

565-0871

Investigator site 0810003, Osaka

Investigator site 0810063, Suita

589-8511

Investigator site 0810007, Osaka

173-8606

Investigator site 0810036, tabashi City

31-202

Investigator site 0480024, Krakow

31-539

Investigator site 0480018, Krakow

90-324

Investigator site 0480020, Lodz

20-093

Investigator Site 0480017, Lublin

07-097

Investigator site 0480022, Warsaw

011302

Investigator site 040001, Bucharest

08035

Investigator site 0340021, Badalona

02000

Investigator site 3100013, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT04280718 - A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) | Biotech Hunter | Biotech Hunter